Ozagrel sodium Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Ozagrel sodium (ozagrel), a thromboxane A2 synthesis inhibitor, is used for patients with noncardioembolic stroke in China, Korea, and Japan. In the Japanese guideline for managing patients with acute ischemic stroke, it is recommended to start administering ozagrel for patients with noncardioembolic ischemic stroke, including atherothrombotic stroke and lacunar infarction, within 5 days after onset, using a dose of 80?mg twice a day for 14 days[1-2].
Ozagrel sodium Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte